These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

326 related articles for article (PubMed ID: 2848408)

  • 1. Neuroendocrine differentiation in endocrine and nonendocrine lung carcinomas.
    Linnoila RI; Mulshine JL; Steinberg SM; Funa K; Matthews MJ; Cotelingam JD; Gazdar AF
    Am J Clin Pathol; 1988 Dec; 90(6):641-52. PubMed ID: 2848408
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The value of neuroendocrine markers in non-small cell lung cancer: a comparative immunohistopathologic study.
    Kiriakogiani-Psaropoulou P; Malamou-Mitsi V; Martinopoulou U; Legaki S; Tamvakis N; Vrettou E; Fountzilas G; Skarlos D; Kosmidis P; Pavlidis N
    Lung Cancer; 1994 Dec; 11(5-6):353-64. PubMed ID: 7535640
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Impact of neuroendocrine differentiation in non-small cell lung cancer. The LCSG experience.
    Linnoila RI; Piantadosi S; Ruckdeschel JC
    Chest; 1994 Dec; 106(6 Suppl):367S-371S. PubMed ID: 7988266
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A comparison of synaptophysin, chromogranin, and L-dopa decarboxylase as markers for neuroendocrine differentiation in lung cancer cell lines.
    Jensen SM; Gazdar AF; Cuttitta F; Russell EK; Linnoila RI
    Cancer Res; 1990 Sep; 50(18):6068-74. PubMed ID: 2168288
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Neuroendocrine markers in lung cancer].
    Shen L
    Zhonghua Bing Li Xue Za Zhi; 1993 Aug; 22(4):201-3. PubMed ID: 8168175
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Reactivity of lung tumors with lung-derived and non-lung-derived monoclonal antibodies.
    Ioachim HL; Pambuccian S; Giancotti F; Dorsett B
    Int J Cancer Suppl; 1994; 8():132-3. PubMed ID: 7515026
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The use of neuroendocrine immunoperoxidase markers to predict chemotherapy response in patients with non-small-cell lung cancer.
    Graziano SL; Mazid R; Newman N; Tatum A; Oler A; Mortimer JA; Gullo JJ; DiFino SM; Scalzo AJ
    J Clin Oncol; 1989 Oct; 7(10):1398-406. PubMed ID: 2550590
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Expression of neuron-specific enolase, chromogranin A, synaptophysin and Leu-7 in lung cancer cell lines.
    Poola I; Graziano SL
    J Exp Clin Cancer Res; 1998 Jun; 17(2):165-73. PubMed ID: 9700577
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Neuroendocrine differentiation in 32 cases of so-called sclerosing hemangioma of the lung: identified by immunohistochemical and ultrastructural study.
    Xu HM; Li WH; Hou N; Zhang SG; Li HF; Wang SQ; Yu ZY; Li ZJ; Zeng MY; Zhu GM
    Am J Surg Pathol; 1997 Sep; 21(9):1013-22. PubMed ID: 9298877
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prognostic value of serum tumor markers in patients with lung cancer.
    Hatzakis KD; Froudarakis ME; Bouros D; Tzanakis N; Karkavitsas N; Siafakas NM
    Respiration; 2002; 69(1):25-9. PubMed ID: 11844959
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Molecular and cellular biology of neuroendocrine lung tumors: evidence for separate biological entities.
    Swarts DR; Ramaekers FC; Speel EJ
    Biochim Biophys Acta; 2012 Dec; 1826(2):255-71. PubMed ID: 22579738
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Gastroenteropancreatic neuroendocrine tumors. A histochemical and immunohistochemical study of epithelial (keratin proteins, carcinoembryonic antigen) and neuroendocrine (neuron-specific enolase, bombesin and chromogranin) markers in foregut, midgut, and hindgut tumors.
    Nash SV; Said JW
    Am J Clin Pathol; 1986 Oct; 86(4):415-22. PubMed ID: 2429541
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Immunocytochemical localization of neuron specific enolase in small cell carcinomas and carcinoid tumours of the lung.
    Sheppard MN; Corrin B; Bennett MH; Marangos PJ; Bloom SR; Polak JM
    Histopathology; 1984 Mar; 8(2):171-81. PubMed ID: 6202617
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Microtubule-associated protein-2: a new sensitive and specific marker for pulmonary carcinoid tumor and small cell carcinoma.
    Liu Y; Sturgis CD; Grzybicki DM; Jasnosz KM; Olson PR; Tong M; Dabbs DD; Raab SS; Silverman JF
    Mod Pathol; 2001 Sep; 14(9):880-5. PubMed ID: 11557784
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Neural cell adhesion molecules (NCAM) and NCAM-PSA expression in neuroendocrine lung tumors.
    Lantuejoul S; Moro D; Michalides RJ; Brambilla C; Brambilla E
    Am J Surg Pathol; 1998 Oct; 22(10):1267-76. PubMed ID: 9777989
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Detection of epithelial- and neural type of intermediate filament proteins in human lung tumors.
    Ramaekers F; Broers J; Rot MK; Oostendorp T; Wagenaar S; Vooijs P
    Acta Histochem Suppl; 1987; 34():45-56. PubMed ID: 3033739
    [TBL] [Abstract][Full Text] [Related]  

  • 17. P16 is a useful supplemental diagnostic marker of pulmonary small cell carcinoma in small biopsies and cytology specimens.
    Švajdler M; Mezencev R; Ondič O; Šašková B; Mukenšnábl P; Michal M
    Ann Diagn Pathol; 2018 Apr; 33():23-29. PubMed ID: 29566943
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pro-gastrin-releasing peptide, neuron specific enolase and chromogranin A as serum markers of small cell lung cancer.
    Lamy PJ; Grenier J; Kramar A; Pujol JL
    Lung Cancer; 2000 Sep; 29(3):197-203. PubMed ID: 10996422
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Insulinoma-associated Protein 1 (INSM1) Is a Better Marker for the Diagnosis and Prognosis Estimation of Small Cell Lung Carcinoma Than Neuroendocrine Phenotype Markers Such as Chromogranin A, Synaptophysin, and CD56.
    Sakakibara R; Kobayashi M; Takahashi N; Inamura K; Ninomiya H; Wakejima R; Kitazono S; Yanagitani N; Horiike A; Ichinose J; Matsuura Y; Nakao M; Mun M; Nishio M; Okumura S; Motoi N; Ito T; Miyazaki Y; Inase N; Ishikawa Y
    Am J Surg Pathol; 2020 Jun; 44(6):757-764. PubMed ID: 32118626
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The prognostic significance of neuroendocrine markers and carcinoembryonic antigen in patients with resected stage I and II non-small cell lung cancer.
    Graziano SL; Tatum AH; Newman NB; Oler A; Kohman LJ; Veit LJ; Gamble GP; Coleman MJ; Barmada S; O'Lear S
    Cancer Res; 1994 Jun; 54(11):2908-13. PubMed ID: 8187076
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.